Maia’s Cord Blood Miracle – Part 2 of 2 - Cord Blood Videos

Umbilical Cord Blood Stem Cells

Offers information about cord blood stem cells benefits and how to preserve your baby's umbilical cord blood through authorised cord blood banks.


Archive for January, 2009

Maia’s Cord Blood Miracle – Part 2 of 2

January 31, 2009 By: admin Category: Cord Blood Videos Comments

rnrnPart 2 of 2 A re-infusion of stem cells taken from umbilical cord blood changed the life of 4-year-old Maia Friedlander, who was developmentally delayed from birth. She received a second chance thanks to a groundbreaking procedure pioneered by Dr Joanna Kurtzberg, a leading pediatric oncologist at Duke University in North Carolina, USA. nnMaias parents first heard about cord blood being used to fix brain injury when Mary Schneider, who was the first person to have the treatment for her son Ryan’s cerebral palsy, visited New Zealand in April this year. Three years on, Mary says Ryan is clear of all issues, needs no more therapies, and is totally well, a typical five-year-old boy. The Friedlanders were determined to get Maia into the Duke programme and emailed and phoned nearly daily for the next four months. They felt they had nothing to lose and owed it to Maia to see whether this could change her life too. Their persistence paid off. nnIn late August, Maia and her mum Jillian flew to Duke to have the stem cells her parents stored with CordBank New Zealand put back into her blood stream via an intravenous drip. Once in her system, its a matter of waiting for her cord blood stem cells to find their way to the damaged tissue in her brain and begin rebuilding it. Jillian didnt have to wait long. Only two days after Maias re-infusion, her balance seemed to have improved. Her eyes became more focused and alert, she could run with confidence and she even started speaking; things she simply hadnt done before.nnhttp://www.cordbank.co.nz/cord-blood-banking/

Technorati Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

Cord Blood Collection – Some Basic Information

January 30, 2009 By: admin Category: Cord Blood Comments

cord blood
Inadequate knowledge about cord blood collection, processing and cord blood storage is pushing many new parents away from donating their babies cord blood cells. Hence, comprehensive information on steps of collection, processing and storage of cord blood cells is required to educate them and help them release their fear of unknown risks, if any, involved in the methods. Cord blood collection methods, whether post or pre delivery don’t expose the child or the mother to any risk and pain. With all the miraculous therapeutic benefits of cord blood cells, a once disposable umbilical cord is now worthy of being stored to retrieve the diverse life saving opportunities from it.

Types Of Blood Cord Collection Methods

Cord blood storage follows two prior steps:

Collection

Processing

First and foremost is the blood cell collection. There are two methods. Both are considered equally safe. Collection methods vary according to the period of collection

Ex utero method implies involves placing the placenta in a sterile supporting structure, where the clamped and cut off umbilical cord is injected with a syringe to drain the blood cells in a bag.

In utero (or before the placenta is delivered) method refers to the collection that takes place when the doctor or the midwife is waiting for placenta to be delivered or the period of 5 to 10 minutes before the delivery of placenta. In utero method involves the same procedure, except its time of collection.

Both women undergoing vaginal and cesarean deliveries can consider donating umbilical cord blood stem cells, as the methods are safe for both types of deliveries. However, if during the final stages of pregnancy, complications arise, the cord blood bank and the physicians may select to abandon the plan for cord blood collection. Along with collecting cord blood cells from umbilical vein, mothers blood gets also collected to detect some infectious diseases as per regulations. Around 40 to 150ml stem cells are drained from the umbilical cords to collect adequate cells for transplantation. The specialists try to collect as cord blood as possible. Incase the blood collected isn’t sufficient, the blood is still preserved for possible stem cell expansion or if the parents agree, for scientific research. After collection, the blood cells are then forwarded to the cord blood bank facility chosen by the parents. Blood bank centers then test and examine blood to detect presence of infectious diseases or typecasting the tissues.

Processing Of Cord Blood Cells

After cord blood banking, samples are transferred to the labs within 36 to 48 hours of collection. Different thoughts have suggested various ways of processing cord cells. Laboratories that are CLIA certified, at the same time, have registered with FDA test moms blood for diseases like syphilis, hepatitis, HLTV, HIV, Malaria and CMV. The processing part, along with ensuring infectious disease status, ensures that blood cells are eligible to be used for transplanting on family members besides autologous use. A point to note here’s that the mother usually has to undergo a special test during cord blood registry to ensure that she is eligible for the cord blood donation. The results are sent to the parents so that they can prepare themselves for treatment if required.

Preservation Of Cord Blood Cells

During processing, cord blood cells are depleted of red blood cells, while some processing methods keep the red blood cells. After processing of cells, comes the next procedure of cord blood preservation. When the unit containing cord blood cells is processed, a cyropreservant is added to it. This is added to make the unit survive the cryogenic process. As the unit drops its temperature to -90 degree Celsius, a liquid nitrogen tank is used for cord blood storage. The units of cord blood are preserved in special bags divided into two compartments. One is for immediate use (if required) and the other is for stem cell expansion.

The childs parents or guardians are given the rights to unit for their transplanting use in future. Later, at the onset of legal age, the child possesses control over his or her cord blood cells. For those worried about privacy issues, the cord blood banks assure the donors for complete secrecy. At no stage will the donors identity be revealed to the recipient, especially if the latter is a stranger.

By: Apurva Shree

About the Author:

n

Cord blood storage in a cord blood bank can save your family from many dreaded diseases. The umbilical cord blood is rich in stem cells, which is used in the treatment of killer diseases. If you decide not to store your babys cord blood in a private cord blood bank, then you can donate it to a public cord blood bank at no cost. Visit Cord Blood Banking for an understanding of types of cord blood banks and their processes.
rn

n

Related Blogs

Technorati Tags: , , , , , , , , , , , , , , , , , , ,

Parents credit cord blood transplant with healing daughter’s brain

January 28, 2009 By: admin Category: Uncategorized Comments

The cheery toddler runs down the hall, waving her arms above her head as she reaches her target.
Chloe Levine, 2 1/2 , jumps into the arms of her dad, Ryan Levine, and the two share a snuggle.
“Running like that with two arms up in the air was impossible before,” says Chloe’s mom, Jenny Levine, 32.
Chloe, who has cerebral palsy, was transplanted with her own stem cells on May 27, 2008, as part of a study at Duke University.
The cells were collected at birth from Chloe’s umbilical cord and frozen, months before her parents knew there was anything wrong with their precious daughter. They were stored in Tucson at Cord Blood Registry, near Tucson International Airport.
Scientists debate whether stem cells can help children such as Chloe, or if the improvement in motor skills would have occurred anyway.
But the Levines believe Chloe’s improvement since the transplant is nothing short of a miracle.
“She’s normal now,” says Jenny Levine, as her daughter colors a picture of Elmo with a bright pink crayon. “She’s doing everything a normal 2-year-old does.”
When Chloe’s parents were expecting her sister, Shayla, now 5, they investigated the possibility of storing her cord blood. But they could not afford the initial $2,000 investment at the time.
When pregnant with Chloe, Jenny Levine was determined to store her second child’s cord blood.
“It was one of the first things we decided,” she said. “There have always been two things in life that scare me the most, cancer and car accidents. We looked at it as a life insurance policy.”
The family was living in Pinetop when Chloe was born. They now live in Denver, where Jenny stays home with the girls and Ryan, 34, is in the cell phone business.
Jenny had a difficult pregnancy, and Chloe was born a month early.
“But every indication was that she was just fine,” she said.
At 9 months, the couple worried that Chloe could not hold her bottle. “Her little right hand was always in a tight fist,” Jenny recalled.
They took her to a pediatrician, who didn’t seem concerned.
“But my instincts told me something was not right,” Jenny said.
At her year check-up, Jenny told the pediatrician she was not crawling, and didn’t put weight on her right side. A brain scan showed Chloe had hemiplegic cerebral palsy, and that she suffered a stroke in utero, probably early in pregnancy. Some of Chloe’s brain tissue, Jenny said, stopped developing.
The family consulted a Phoenix neurologist. “I told him we had cord blood stored, and asked if there was any possible use,” Jenny recalled. “He said, “No, it won’t benefit you.’ ”
They were told Chloe would need physical, occupational and speech therapy throughout her childhood. ”We trusted what he had to say, accepted what we had to do and we went home,” Jenny said.
In December 2007, the family heard about Dallas Hextell, a Sacramento boy with cerebral palsy who had been infused with his own stem cells as part of the study at Duke, and was responding well.
“I immediately got in contact with Duke,” Jenny said. The hope, she said, is that the infusion of stem cells could cause brain tissue to regenerate, improving Chloe’s mobility.
“They will not guarantee you anything,” Jenny said, “The worst that can happen is nothing happens.”
“We didn’t have any expectations, but we wanted to know we had tried everything,” Ryan said.
Last May, Chloe’s stored stem cells were tested and sent to Duke, where she was infused through an IV in her arm. Her parents say they saw a nearly immediate change.
“She woke up the next day and she was a different kid,” Jenny said. “Two days later, in the car, she said her first word, ‘Coco,’ her nickname.”
At her grandparents’ house a couple of days after infusion, Chloe was able to use her right foot to push the pedal of a toy tractor, something she had not been able to do before.
The family will return to Duke in May or June for evaluation. Dr. Joanne Kurtzberg, the Duke transplant specialist who treated Chloe, is not granting media interviews, and the study is still in it’s early stages.
But the Levines believe the transplant is saving their daughter.
“It has been life-changing in every aspect,” Jenny said. “She no longer needs speech therapy, and we are seeing improvement every day. It’s amazing.”
AAP cord blood recommendations
When deciding whether to bank your baby’s cord blood, discuss the options with your obstetrician. Here is what to consider when deciding which company to select, according to the American Academy of Pediatrics:
Does the company bank for personal and family use?
Institutional Review Board-approved protocols should be in place, including annual disclosure of the financial interest and potential conflicts of interest.
Financial viability and stability of the company should be considered.
Physician should disclose any potential conflict of interest.
Company should have an informed consent process in place and require the parent to sign an informed consent.
Cord blood banks should comply with national accreditation standards developed by the Foundation for the Accreditation of Cellular Therapy, the U.S. Food and Drug Administration, the Federal Trade Commission and similar state agencies.

Technorati Tags: , , , , , , , , , , , , , , , , , , ,

Saving child’s cord blood: medicine or marketing?

January 28, 2009 By: admin Category: Uncategorized Comments

Last spring, Chloe Levine dragged her tiny right foot as she struggled to walk.
The toddler’s right hand remained clenched in a fist. She did not speak, and her eyes were glazed over.
Cerebral palsy caused by a stroke in utero prevented Chloe from developing like other children.
But after an experimental infusion of her own stem cells – collected from her umbilical cord at birth, frozen and stored in Tucson – Chloe, 2 1/2, is running, kicking a soccer ball and coloring.
“It’s my prayer that some day we can erase the diagnosis,” said Chloe’s mom, Jenny Levine, a former Pinetop resident who lives in Denver. “Even if that doesn’t happen, she’s come a heck of a long way.”
Chloe, who is part of a trial at Duke University, is one of 33 patients who last year were infused with their own stem cells that had been taken from their umbilical cords and stored in Tucson at Cord Blood Registry. It is the largest private cord blood bank, storing a quarter of a million units from around the world.
The number of transplants of a person’s own stem cells through CBR tripled in 2008, as more transplants are conducted in trials in regenerative medicine. Scientists are studying whether an infusion of a person’s own cells collected at birth can repair damaged tissues.
“We really look at what we do as providing hope for longer, healthier lives,” said Tom Moore, CBR’s founder and CEO.
“When we are talking about regenerative medicine, we are talking about cures.”
Parents spend $2,000 initially for cells to be collected and stored, and about $125 a year for maintenance.
Use of the cells is not politically controversial, as in the case of embryonic stem cells.
But marketing strategies of businesses that store the cells are. The American Academy of Pediatrics, which many concerned parents turn to regarding the health of their child, recommends privately banking cells only if an ill older sibling might benefit.
Storing cord blood as “biological insurance” should be discouraged because there is no scientific data to support that transplanting a person’s stem cells works, it says.
“Private cord blood banks target parents at an emotionally vulnerable time when the reality is most conditions that might be helped by cord blood stem cells already exist in the infant’s cord blood,” according to the academy’s Web site.
The academy strongly recommends donating cord blood to a public bank. Donations, which cannot later be retrieved by the family, can help others battling illness.
No public bank exists in Arizona. But Tucsonans can donate through Cryobanks International in Altamonte Springs, Fla. (See box.)
Additionally, some in the scientific community question whether patients like Chloe were likely to improve without the transplant.
Cord Blood Registry officials call the academy’s statement “outdated” at a time when the science of cord blood stem cells is changing and expanding rapidly.
They also say they are educating parents, not encouraging them to bank based on fear.
Cord blood stem cells are being used experimentally to treat brain injuries like Chloe’s, Type 1 diabetes, heart disease and other illnesses. CBR officials say the cells potentially hold the cure for more than 70 diseases.
Moore and his staff say they believe one day a person’s stem cells might be used to cure everything from hearing loss to knee injuries.
“I think some day, kids will talk about stem cell transplants like getting a flu shot,” said Dondi Pulse-Earle, who coordinates transplants at CBR. “It will be, ‘Hey, have you used your stem cells yet?’ ”
Nationally, there are about 30 private banks. CBR started in 1992 after Moore said he discovered the best research was conducted by University of Arizona immunologist David Harris.
Harris, who is also CBR’s scientific director, has been researching stem cells since 1989 and started the bank here with his son’s cord blood.
The bank is now housed in a 60,000-square-foot state-of-the-art facility near the Tucson International Airport. Tucson was also selected because of few instances of natural disasters that could shut down the airport or the bank.
Harris agrees public banking is needed. One operated in Tucson for a decade, until funding ran out, he said.
The state was expected to start public banking again this year after the Arizona Legislature approved $5 million over five years to fund the project, Harris said.
But the bank was a victim of the budget crisis and funding was cut, he said. He predicts it will be years before a public bank will be funded.
Public banks are especially needed for minority patients and those of mixed race, who are less likely to have stored cells privately, he said.
Harris said the American Academy of Pediatrics has put parents in a tough spot by only recommending public banking.
“If you’re going to tell me to donate, you need to make sure I can donate,” he said of the limited public banks available.
While 22 states are approved for public banking, only six collect donated cord blood stem cells from births at specific hospitals, Harris said.
But Dr. William T. Shearer, the professor of pediatrics and immunology at Baylor College of Medicine who helped write the academy’s position on private storing, said families can donate to public banks, but they must be proactive, finding a bank in a different state.
Shearer said the academy’s position is not outdated.
He called claims of being able to fix future disease and injury using a person’s own cells “a little far fetched, frankly.”
But he said the uses of donated cells are immediate and greatly needed.
Private banks argue that transplants with a person’s cells are more effective and safer. But Shearer said effectiveness has not been proved.
“This goes beyond medicine and into marketing,” he said.
But Harris argues the use of one’s own stem cells has tremendous potential to cure.
At UA, he has conducted research into how stem cells affect cerebral palsy and other traumatic brain injuries, as well as Type 1 diabetes.
Harris found that cord blood stem cell transplants cured mice of diabetes over the span of their life, about two years.
A study of 23 children with Type 1 diabetes at the University of Florida has shown improvements when they are infused with their own stem cells. Some children are making their own insulin, Harris said.
What is not known is whether the disease will reoccur, he said.
While much about regenerative medicine is unknown, Harris said changes in patients make it impossible to dismiss.
“When you see enough patients benefiting, you say, ‘Something’s going on here.’ ”
Harris agreed there are probably private companies that market to parents’ fears, but he says CBR is not one of them.
His advice to expectant parents: “Make an informed decision early on. You only have one opportunity. Make a decision and don’t look back. You don’t want to do this out of fear. You want to consider it if you think it could be a viable resource that you can call upon should you need it.”
Tucson parents Heather and Gary George had no doubts when it came to storing their children’s cord blood.
They have stored stem cells of children Isabelle, 2 1/2, and Jasper, 16 months, and plan to store the cells of their third child, due Jan. 27.
“I’m a nurse, and I know about stem cells and the fantastic opportunities available in the future for therapies,” said Heather George, 32. “Knowing what I know, I could not have chosen not to save the cord blood.”
They chose to store at CBR because of the few major weather disasters that could shut down the facility. They also like that the blood does not have to travel across the country.
She knows it is unlikely her children will ever need the cells.
“But heaven forbid something happen, how awful that would be if we had not saved them,” she said.
For some parents, the peace of mind they get saving cells is worth the investment, said Dr. David Beyda, a medical ethicist, critical care doctor at Phoenix Children’s Hospital and a UA clinical professor of pediatrics.
Beyda is not familiar with CBR, but he spoke in general of ethical concerns regarding private cord blood banking.
“What’s it worth to you as a parent? Is it peace of mind? If it is, then do it,” Beyda said. “If you think it’s a guarantee (of a cure for any future illness), then be cautious.”
Ethical concerns are raised, he said, when companies play on the fears of expectant parents through advertising.
Marketing techniques that use the potential for guilt are unethical, Beyda said.
“What happens if your child at age 5 gets leukemia? Do you want your child to die?” is the marketing strategy used by some companies, he said.
Beyda said the number of transplants nationally is very small, and viability as a long-term fix is unknown.
“When you look at scientific information, it’s extremely sparse in terms of evidence that it’s beneficial,” he said.
The American College of Obstetricians and Gynecologists released guidelines last year, recommending that health-care professionals provide balanced information on private and public banking. But its Web site says chances are “remote” that cells from a baby’s banked cord blood will be used to treat that child or another family member.
CBR, however, says there is “solid scientific evidence” from animal studies that transplants can induce healing and that the uses are likely to expand.
In addition to the 33 stem cell transplants through CBR last year where patients received their own cells, another seven transplants were used to treat siblings, according to CBR.
Moore, of CBR, said the possible uses are far reaching.
“If you can provide a positive outcome in that child and make them whole again, you can have a significant impact,” he said.

Technorati Tags: , , , , , , , , , , , , , , , , , , ,

Comparison Between Bone Marrow or Peripheral Blood Stem Cells and Cord Blood Donated for Transplantation

January 28, 2009 By: admin Category: Uncategorized Comments

Bone Marrow/Peripheral Blood Cord Blood
Donation requires surgery under general anesthesia. Donors may experience temporary discomfort and/or pain. Long-term consequences of growth factors used in peripheral blood stem cell donations are uncertain. When obtained from the delivered placenta and umbilical cord, donation poses no risk to mother or infant.

Requires donation of a quart or more of bone marrow (mixed with blood) for transplant.

A few ounces can be used for transplantation.
Large dose of stem cells. Rapid engraftment. Smaller dose of stem cells. Slower engraftment.

After a formal search is begun, takes an average of 4 months to transplant, if a donor is available.

When a match is found, can take only a few days for confirmatory and special testing and shipment to the Transplant Center (less than 24 hours in an emergency).

Potential donors may no longer be available or may have withdrawn consent. Donor must be found and retested to confirm the HLA typing and infectious disease results and to confirm that the donor is still willing and able to donate bone marrow. Significant donor attrition. Once frozen, a cord blood unit is available until used. Otherwise, no donor attrition.

Donor may be available to give a second transplant or to donate T-cells if necessary.

Donor is not available for a second donation.
Bone marrow must be used fresh (shelf-life measured in hours). Peripheral blood stem cells stored for short term (days to a few months). Frozen cord blood has been transplanted successfully after up to 10 years in storage.

Patient must begin conditioning before the bone marrow harvest. Coordination between donation and transplant is critical and complex.

Can be shipped to the transplant center before the patient enters the hospital and begins conditioning for transplantation. Coordination is simple. Cord blood units are shipped on demand.

Latent viral infection in the donor common (i.e. CMV > 50% in U.S. adult donors). Latent viral infection in the cord blood donor rare (i.e. CMV <1% in U.S.).

No risk of transplanting a genetic disease.

Cord blood has a small risk that a rare, unrecognized genetic disease affecting the blood or immune system will be given with the transplant.

Severe graft vs host disease (GvHD) common. GvHD less frequent and usually less severe and easier to treat.

Generally requires a perfect match between donor and recipient for 6/6 HLA-A, -B and -DRB1 antigens. Additional HLA factors (HLA-C, -DQ and -DP) increasingly used to improve prognosis.

HLA-mismatched cord blood transplants are possible, making it easier to find a suitable match. Role of HLA-C, -DQ and -DP are not yet known.

 

Technorati Tags: , , , , , , , , , , , , , , , , , , ,

Cord Blood: A Solution for Bone Marrow Transplantation

January 28, 2009 By: admin Category: Uncategorized Comments

Over 20,000 new patients each year are diagnosed with a lethal disease that is curable with a bone marrow transplant. One-third has a relative (usually a brother or sister) that matches their tissue type (HLA) and can donate bone marrow.

Two-thirds of these patients have no relative who is a suitable donor.

Bone marrow donated by a person who is not a relative can provide the needed stem cell source.

Bone marrow transplants generally must be fully matched for 8 out of 8 HLA antigens (with a trend toward trying to find a donor that matches for as many as 12 HLA alleles, if possible).
The National Marrow Donor Program (NMDP) has some 6,000,000 registered potential donors who volunteer to donate their marrow. Another 3,000,000 are available in other US and foreign registries.
When a match is found among registered marrow donors, only about one-third are actually available. Others may no longer be willing or pass the health requirements or simply cannot be found.
NMDP helps 1,500 2,000 patients each year get a bone marrow transplant from an unrelated donor.
Minority patients have special difficulty in finding a matching unrelated marrow donor. Only 6% of patients who have succeeded in getting a bone marrow transplant through NMDP are African-American, compared to 12% of those who searched for a donor and 12% of the US population.

Cord blood donated to a public Cord Blood Bank is an alternate stem cell source.

Cord blood transplants do not need to be a perfect match. Patients are alive and well who have gotten cord blood that only matches for 4 of 6 HLA antigens.
Patients do better, however, with cord blood that is a good match and provides a good cell dose.
A 5 of 6 cord blood transplant can do as well as 6 of 6 marrow transplant. And 6 of 6 do better!
Cord blood works for adults (November 28, 2004, New England Journal of Medicine), leading Nelson Chow, MD, Head of the Adult Marrow Transplant Program at Duke University, to declare Cord blood is now ready for prime time. (American Society for Hematology, December 2004).
150,000 cord blood units would provide all patients an 80-90% chance of finding a 5 of 6 HLA match (and a 6 of 6 for about 30%) (based on an analysis of the New York Blood Center experience).
Cord blood is frozen and ready to go. When a suitable cord blood unit is found, it is guaranteed to be available and can be dispatched to a patient within one week (24 hours in an emergency).
Minority patients, and others with rare tissue types, benefit from cord blood as a source of stem cells since matches do not have to be perfect. African-Americans constitute 19% of the 1,276 US patients who have gotten cord blood transplants from the New York Blood Centers Program, for example. Altogether, ethnic minority patients constitute 44% of NYBC cord blood recipients.

Goal of the Legislation:

Cord Blood Banks need help through federal funding to build a national inventory of 150,000 high quality cord blood units from ethnically diverse donors in order to serve all patients effectively. After five years of federal support, Cord Blood Banks will become self-sustaining and no longer need support.
.
The Future:

Cord blood will become the preferred source of stem cells for transplantation if no related donor is available.

Technorati Tags: , , , , , , , , , , , , , , , , , , ,

Advantages of cord blood

January 28, 2009 By: admin Category: Cord Blood Banking Comments

What are the advantages of cord blood?

Cord blood offers a number of advantages to donors and transplant recipients. It is easy to collect, more likely to provide a suitable match and is stored frozen, ready to use.

1. Cord blood collection is easy and risk-free.
Cord blood collection is a safe, simple procedure. The New York Blood Center’s National Cord Blood Program staff collects cord blood from the delivered placenta, which does not interfere with the care of the mother or newborn baby. Collection, therefore, poses no risk to mother or baby.

2. Cord blood is collected in advance, tested and stored frozen, ready to use.
Cord blood is donated in advance for anyone who might need it in the future. All routine testing is completed and the unit is stored frozen, ready to use. If a match is found, it can be reserved immediately. Confirmatory HLA typing and any special testing required is usually completed within 5-7 days. Unlike bone marrow, there is no need to take time to locate a possible volunteer and then determine whether he or she is still willing and able to donate.

3. Cord blood doesn’t require a perfect match.
The ability to transplant cord blood with only a partial donor-recipient match is its greatest advantage. Bone marrow usually requires a 6/6 HLA match between the donor and recipient. Cord blood has been transplanted successfully with as few as 3/6 matches, although patients do best when their cord blood graft is at least a 5/6 match.

Because partially matched cord blood transplants are acceptable, cord blood offers patients a better chance to find a suitable donor. With cord blood, a relatively small donor pool can effectively support most patients’ needs. We estimate, for example, that a national inventory of 150,000 cord blood units would provide 6/6 or 5/6 matches for at least 80-90% of patients in the United States.

4. Cord blood poses fewer risks of certain complications to the recipient.
The immune cells in cord blood seem to be less likely than those in bone marrow from unrelated donors to attack the patient’s own tissues (graft vs. host disease). Cord blood is also less likely to transmit certain viruses, like cytomegalovirus (CMV), a potentially lethal infection for transplant recipients. CMV is carried as a latent virus by about half of the adult U.S. population, whereas less than 1 percent of infants are born with CMV.

Related Blogs

Technorati Tags: , , , , , , , , , , , , , , , , , , ,

The need to have cord blood donated to public cord blood banks

January 28, 2009 By: admin Category: Uncategorized Comments

Why do we need to have cord blood donated to public cord blood banks?

1. Cord blood donated to a public bank provides another source of hope for patients who have no matching donor in their own family, no unrelated donor in bone marrow donor registries that is a suitable match or no time to find a donor. Increasingly, cord blood is becoming the first choice for children as a source of stem cells. Just like bone marrow, cord blood stem cells are capable of generating all the cellular elements in the blood and immune system.

2. Donated bone marrow or peripheral blood containing mobilized stem cells have been the traditional sources of hematopoietic stem cells for transplantation. Their donors usually must be perfectly matched to the recipient; that is, matched at least for the HLA-A, -B and -DRB1 antigens. Since there are usually two antigens for each, in a perfect match, the donor will have the same six antigens as the patient, a 6/6 match. A perfect match is easiest to find among family members. A brother or sister of a patient, for example, has a 25% chance of being a perfect match. Because the average number of children in U.S. families is slightly more than two, about 3 out of 10 patients will find a match among their own siblings. Other blood relatives also may be well-matched but the chance is much lower.

When no relative is available, some other source of stem cells must be found. Bone marrow for unrelated donors has helped solve this problem for several thousand patients. Marrow donor registries around the world have recruited several million volunteers willing to donate their bone marrow to a perfect stranger. The largest registry in the United States is the National Marrow Donor Program (NMDP) which lists over 5 million volunteers.

3. Many patients who need a bone marrow transplant, however, cannot find a suitable donor – no relative that matches and no match among volunteer bone marrow donors. According to a report from the U.S. Government Accounting Office (GAO) released in October 2002, 10,000-15,000 people in the U.S. each year have a disease that could be treated with a transplant, but have no HLA-matched related donor. About one-third of these patients try to find an unrelated marrow donor through the NMDP but only 25% of them (9% of the total who might benefit) actually get a transplant. The odds are even worse for African-American and other ethnic minority groups.

4. Fortunately, a cord blood transplant does not have to be a perfect match to the patient. Adult bone marrow contains immune cells (so-called T-lymphocytes or T-cells) that are fully mature. When transplanted, these T-cells may attack the patient’s own cells, causing a condition called graft vs. host disease (GvHD), which can be severe and even lethal. T-cells in cord blood do not appear to be as “immunologically mature” as those in bone marrow. As a result, cord blood transplants are less likely than bone marrow to cause GvHD and, when it does occur, is often less severe. Because cord blood transplants cause less GvHD, the match to the patient does not need to be perfect. In fact, most cord blood transplants so far have been 5/6 or 4/6 matches for HLA-A, -B and -DRB1 antigens. This means that patients who cannot find a perfectly matched bone marrow donor may have a chance to find a suitable cord blood transplant. Patients with rare HLA types, African-Americans and members of other minority groups, therefore, benefit especially from this stem cell resource.

Technorati Tags: , , , , , , , , , , , , , , , , , , ,

Maia’s Cord Blood Miracle – Part 1 of 2

January 28, 2009 By: admin Category: Cord Blood Videos Comments

Part 1 of 2 A re-infusion of stem cells taken from umbilical cord blood changed the life of 4-year-old Maia Friedlander, who was developmentally delayed from birth. She received a second chance thanks to a groundbreaking procedure pioneered by Dr Joanna Kurtzberg, a leading pediatric oncologist at Duke University in North Carolina, USA.

Maias parents first heard about cord blood being used to repair brain injury when Mary Schneider, who was the first person to have the treatment for her son Ryan’s cerebral palsy, visited New Zealand in April this year. Three years on, Mary says Ryan is clear of all issues, needs no more therapies, and is completely well, a typical five-year-old boy. The Friedlanders were determined to get Maia into the Duke programme and emailed and phoned almost daily for the next four months. They felt they had nothing to lose and owed it to Maia to see whether this could change her life too. Their persistence paid off.

In late August, Maia and her mum Jillian flew to Duke to have the stem cells her parents stored with CordBank New Zealand put back into her blood stream via an intravenous drip. Once in her system, its a matter of waiting for her cord blood stem cells to find their way to the damaged tissue in her brain and start rebuilding it. Jillian didnt have to wait long. Only two days after Maias re-infusion, her balance seemed to have improved. Her eyes became more focused and alert, she could run with confidence and she even started talking; things she simply hadnt done before.

http://www.cordbank.co.nz/cord-blood-banking/

Technorati Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

Adult stem cells

January 28, 2009 By: admin Category: Uncategorized Comments

Although stem cells have defining characteristics, they do have different sources. Adult stem cells, also called somatic stem cells, possess the same basic characteristics of all stem cells. An adult stem cell is an unspecialised cell that is capable of:

* Long term renewal
* Differentiation into specialised cell types

In humans, the key functions of adult stem cells are to maintain and repair the specific tissues where they reside. The precise origin of adult stem cells in mature tissues is also still unknown, contrasting with embryonic stem cells, which are defined by their origin.

What Makes Adult Stem Cells So Useful?
One of the reasons research has been so intriguing with adult stem cells is because researchers have discovered adult stem cells in more tissues than they originally anticipated. The use of embryonic stem cells has generated a lot of controversy so the possibility of using adult stem cells for transplants is an exciting one. Adult stem cells have actually been used for decades for bone marrow transplants but more uses are needed to treat other debilitating and life threatening diseases. It appears that some types of adult stem cells can differentiate into different cell types but this is very much dependent on the conditions being appropriate. Scientists hope that by gaining control over this process of differentiation within a laboratory setting, adult stem cells can become the root of therapies used to treat some of the most common but serious diseases.

Where Are Adult Stem Cells Found?
Adult stem cells have been found in many tissues but their numbers are, however, very small. It is suggested that stem cells will remain in a particular area of a tissue for years without dividing. They are then triggered to divide by disease or tissue damage. Adult tissues that are thought to contain stem cells include:

* Skin
* Bone marrow
* Brain
* Blood vessels
* Liver
* Skeletal muscle

Adult stem cells are generally isolated from an adult tissue sample; thus far, they have mostly been examined in humans and a few other animal models. Scientists are questioning whether adult stem cells are still originally derived from embryonic stem cells or if another source is involved.

Benefits of Adult Stem Cells
Adult stem cells have the potential to replenish a person’s trillions of specialised cells from just a few unspecialised cells. The idea of adult stem cell therapy is to control and guide the growth of adult stem cells within a laboratory and then use these to replace dysfunctional cells that are present in disease. Some of the possible treatments involve the replacement of cells in the brains of people who have Parkinson’s disease. Scientists hope to replace the dopamine producing cells and reduce progression of the disease.

Another goal is to develop insulin-producing cells for diabetes. With heart attacks causing enormous morbidity and mortality each year, it is also hoped that adult stem cells can repair damage to the heart.

The use of adult stem cells is more widely accepted, particularly by the public, because it does not require destruction of an embryo as with embryonic stem cells. Adult stem cells also don’t have the same immunological challenges as embryonic stem cells because they are harvested from the patient. This means that a person’s body is less likely to reject the stem cells because they are compatible with that person’s unique physiological makeup.

Challenges of Adult Stem Cells
Unfortunately, adult stem cells are present in miniscule quantities and this can present difficulty for identifying and isolating them in numbers great enough to use therapeutically. Their self-renewal is also not as successful as embryonic stem cells and as such, they do not proliferate to the same degree. Because adult stem cells aren’t as ‘young’ as embryonic stem cells, they contain more DNA abnormalities acquired with age. These can be caused by the environment, toxins or errors in DNA replication.

Overall, adult stem cells don’t pose the same ethical concerns and controversy in comparison with embryonic stem cells, but their practical challenges are numerous. As scientists continue to seek ways to effectively harvest adult stem cells, the public can await new treatments for some of the more serious and common diseases.

Technorati Tags: , , , , , , , , , , , , , , , , , ,


SEO Powered by Platinum SEO from Techblissonline